ea0098c47 | Clinical – Surgery/Applied Pathology | NANETS2023
Mohamed A.
, Fasih A.
, Ocuin L.M.
, Winter J.
, Ammori J.
, Hardacre J.
, Mahipal A.
, Bajor D.
, Chakrabarti S.
, Asa S.L.
, Selfridge J.E.
, Tirumani S.H.
, Henke L.E.
, Hoehn R.S
Background: The role of surgical cytoreduction for metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) is considered an area of debate due to lack of prospective data. While retrospective and single institution analyses demonstrated higher survival rates associated with surgical cytoreduction, there was no comparison with systemic therapies alone in these studies. The aim of this analysis of the National Cancer Database (NCDB) was to evaluate the survival benefi...